1. Home
  2. IPO
  • Innova Captab Ltd Ipo
74713
Off
Innova Captab IPO

Innova Captab IPO

  • Status: Closed
  • RHP:
  • ₹ 14,058 / 33 shares

    Minimum Investment

IPO Details

  • Open Date

    21 Dec 2023

  • Close Date

    26 Dec 2023

  • Listing Date

    29 Dec 2023

  • IPO Price Range

    ₹ 426 to ₹ 448

  • IPO Size

    ₹ 570 Cr

  • Listing Exchange

    BSE, NSE

With just a few clicks, Invest in IPOs!

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Financials SWOT FAQ Contacts

IPO Timeline

Innova Captab IPO Subscription Status

Last Updated: 26 December 2023 6:58 PM by rahul_raskar

Established in 2005, Innova Captab Limited operates as an integrated pharmaceutical company. It has a comprehensive value chain for pharma products which includes research and development, manufacturing, drug distribution and marketing and exports. 

The company has three major business categories:

●    Contract development and manufacturing organization (CDMO): Offers manufacturing facility to Indian pharma companies 
●    Domestic branded generics business 
●    International branded generics business. 

As of FY23 and for the June quarter ending in June 2023,  the company has produced a portfolio of 600+ diverse generics products. Additionally, the company has a network of around 5,000+ distributors and stockists and 150,000+ retail pharmacies. For the same period, Innova Captab has also exported its branded generic products to 20 countries and 16 countries respectively. 
Innova Captab has two manufacturing units based in Baddi, Himachal Pradesh. Some of the popular clients of Innova Captab include Cipla Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Corona Remedies Private Limited, Emcure Pharmaceuticals Limited, Lupin Limited, and Intas Pharmaceuticals Limited. 

Peer Comparison

●    Ajanta Pharma Limited
●    Torrent Pharmaceuticals Limited
●    Laurus Labs Limited
●    J. B. Chemicals and Pharmaceuticals Limited
●    NATCO Pharma Limited
●    Eris Lifesciences Limited
●    Indoco Remedies Limited
●    Suven Pharmaceuticals Limited
●    Windlas Biotech Limited

 

For More Information:
Innova Captab IPO GMP
Webstory on Innova Captab IPO
Know About Innova Captab IPO

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY22 FY21
Revenue from operations 926.38 800.52 410.66
EBITDA 122.84 98.90 55.85
PAT 67.95 63.95 34.50
Particulars (in Rs. Crores) FY23 FY22 FY21
Total Assets 704.41 575.47 369.61
Share Capital 48.00 12.00 12.00
Total Borrowings 427.90 366.86 224.79
Particulars (in Rs. Crores) FY23 FY22 FY21
Net cash generated from / (used in) operating activities 67.12 58.90 41.57
Net cash from / (used in) investing activities -90.84 -188.11 -19.66
Net cash flow from / (used in) financing activities 27.09 124.57 -19.33
Net increase (decrease) in cash and cash equivalents 3.37 -4.64 2.56


Strengths

1.    The company has a leading presence and is one of the fastest-growing CDMOs in the Indian pharmaceutical formulations market.
2.    It has well-established relationships with its marquee CDMO customer base.
3.    Its options are highly efficient, including its world-class manufacturing facilities and supply chain.
4.    The company is focused on rapidly growing domestic and international export branded generics businesses.
5.    Strong R&D focus to build an increasingly complex product portfolio and attract and retain customers.
6.    Consistent financial performance is a big plus. 
7.    Experienced promoters and management team.
 

Risks

1.    Operates in a highly competitive market.
2.    It has substantial working capital requirements and working capital expenditure.
3.    The company is dependent on China, China SEZ and Hong Kong for raw material supplies, exposing it to political, economic and social conditions in greater China.
4.    Any reforms in the healthcare industry and the uncertainty associated with pharmaceutical pricing can impact the business. 
5.    The pharmaceutical market is subject to extensive regulation.
6.    The company has a dependency on distributors and stockists for the sale and distribution of products.
7.    Faces foreign exchange risks.
 

Will You Apply for Innova Captab IPO?

Yes No Maybe

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

The minimum lot size of Innova Captab IPO is 33 shares and the investment required is ₹14,058.

The price band of Innova Captab IPO is ₹426 to ₹448 per share.

The Innova Captab IPO is open from 21st December to 26th December 2023.
 

The size of Innova Captab IPO is around ₹570 cr. 

The share allotment date of Innova Captab IPO is 27th of December 2023.

The Innova Captab IPO will be listed on 29th of December 2023.

ICICI Securities Limited and JM Financial Limited are the book-running lead managers for Innova Captab IPO.

The proceeds from this public issue will be used for:

●    To fund working capital requirements. 
●    To invest in its subsidiary UML.
●    To prepay or repay full/partial borrowings obtained by the company and its subsidiary UML. 
●    General corporate purpose.  
 

To apply for Innova Captab IPO, follow the steps given below:

●    Login to your 5paisa account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for the Innova Captab IPO   
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange  
●    You will receive a mandate notification to block funds in your UPI app.